NASOPHARYNGEAL CARCINOMA

This blog is a collection of my favorite new treatments for nasopharyngeal carcinoma currently available through clinical trials. The start of each post contains a brief description of the approach, reasons I included it and a link to the trial website

Concurrent Chemo-Radiation During Primary Treatment Reduces Recurrence Due to Micro-Metastasis

It is well accepted that micro-metastasis of the primary tumor is responsible for disease recurrence and metastasis. However, by the time most primary tumors are detected using standard diagnostic assays, distant micro-metastasis has likely occurred… [Learn More…]

T Cell Therapy for EBV-Positive Nasopharyngeal Carcinoma

One of the causes of Nasopharyngeal Carcinoma (NPC) is an oncogenic protein made by the Epstein-Barr virus (EBV), referred to as the latent membrane protein 1 (LMP1). EBV-specific cytotoxic T cells (EBV-CTLs) therapy is a process where T-cells are… [Learn More…]